Please select the option that best describes you:

For recurrent glioblastoma treated with combined re-irradiation and bevacizumab, how long do you continue bevacizumab?   

Would you continue it until progression of disease? Or would you switch immediately to next line systemic therapy?



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more